Micelles as potential drug delivery systems for colorectal cancer treatment

World J Gastroenterol. 2022 Jul 7;28(25):2867-2880. doi: 10.3748/wjg.v28.i25.2867.

Abstract

Despite the significant progress in cancer therapy, colorectal cancer (CRC) remains one of the most fatal malignancies worldwide. Chemotherapy is currently the mainstay therapeutic modality adopted for CRC treatment. However, the long-term effectiveness of chemotherapeutic drugs has been hampered by their low bioavailability, non-selective tumor targeting mechanisms, non-specific biodistribution associated with low drug concentrations at the tumor site and undesirable side effects. Over the last decade, there has been increasing interest in using nanotechnology-based drug delivery systems to circumvent these limitations. Various nanoparticles have been developed for delivering chemotherapeutic drugs among which polymeric micelles are attractive candidates. Polymeric micelles are biocompatible nanocarriers that can bypass the biological barriers and preferentially accumulate in tumors via the enhanced permeability and retention effect. They can be easily engineered with stimuli-responsive and tumor targeting moieties to further ensure their selective uptake by cancer cells and controlled drug release at the desirable tumor site. They have been shown to effectively improve the pharmacokinetic properties of chemotherapeutic drugs and enhance their safety profile and anticancer efficacy in different types of cancer. Given that combination therapy is the new strategy implemented in cancer therapy, polymeric micelles are suitable for multidrug delivery and allow drugs to act concurrently at the action site to achieve synergistic therapeutic outcomes. They also allow the delivery of anticancer genetic material along with chemotherapy drugs offering a novel approach for CRC therapy. Here, we highlight the properties of polymeric micelles that make them promising drug delivery systems for CRC treatment. We also review their application in CRC chemotherapy and gene therapy as well as in combination cancer chemotherapy.

Keywords: Chemotherapy; Colorectal cancer; Combination cancer therapy; Drug delivery; Gene therapy; Polymeric micelles.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Colorectal Neoplasms* / drug therapy
  • Drug Carriers
  • Drug Delivery Systems
  • Humans
  • Micelles
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Polymers / therapeutic use
  • Tissue Distribution

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Micelles
  • Polymers